Cargando…

Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial

Radical cystectomy, which is performed to treat muscle-invasive bladder tumors, is among the most difficult urological surgical procedures and puts patients at risk of intraoperative blood loss and transfusion. Fluid management via stroke volume variation (SVV) is associated with reduced intraoperat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Yu-Gyeong, Kim, Ji Yoon, Yu, Jihion, Lim, Jinwook, Hwang, Jai-Hyun, Kim, Young-Kug
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902548/
https://www.ncbi.nlm.nih.gov/pubmed/27175706
http://dx.doi.org/10.1097/MD.0000000000003685
_version_ 1782437017953501184
author Kong, Yu-Gyeong
Kim, Ji Yoon
Yu, Jihion
Lim, Jinwook
Hwang, Jai-Hyun
Kim, Young-Kug
author_facet Kong, Yu-Gyeong
Kim, Ji Yoon
Yu, Jihion
Lim, Jinwook
Hwang, Jai-Hyun
Kim, Young-Kug
author_sort Kong, Yu-Gyeong
collection PubMed
description Radical cystectomy, which is performed to treat muscle-invasive bladder tumors, is among the most difficult urological surgical procedures and puts patients at risk of intraoperative blood loss and transfusion. Fluid management via stroke volume variation (SVV) is associated with reduced intraoperative blood loss. Therefore, we evaluated the efficacy and safety of SVV-guided fluid therapy for reducing blood loss and transfusion requirements in patients undergoing radical cystectomy. This study included 48 patients who underwent radical cystectomy, and these patients were randomly allocated to the control group and maintained at <10% SVV (n = 24) or allocated to the trial group and maintained at 10% to 20% SVV (n = 24). The primary endpoints were comparisons of the amounts of intraoperative blood loss and transfused red blood cells (RBCs) between the control and trial groups during radical cystectomy. Intraoperative blood loss was evaluated through the estimated blood loss and estimated red cell mass loss. The secondary endpoints were comparisons of the postoperative outcomes between groups. A total of 46 patients were included in the final analysis: 23 patients in the control group and 23 patients in the trial group. The SVV values in the trial group were significantly higher than in the control group. Estimated blood loss, estimated red cell mass loss, and RBC transfusion requirements in the trial group were significantly lower than in the control group (734.3 ± 321.5 mL vs 1096.5 ± 623.9 mL, P = 0.019; 274.1 ± 207.8 mL vs 553.1 ± 298.7 mL, P <0.001; 0.5 ± 0.8 units vs 1.9 ± 2.2 units, P = 0.005). There were no significant differences in postoperative outcomes between the two groups. SVV-guided fluid therapy (SVV maintained at 10%–20%) can reduce blood loss and transfusion requirements in patients undergoing radical cystectomy without resulting in adverse outcomes. These findings provide useful information for optimal fluid management during radical cystectomy.
format Online
Article
Text
id pubmed-4902548
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49025482016-06-27 Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial Kong, Yu-Gyeong Kim, Ji Yoon Yu, Jihion Lim, Jinwook Hwang, Jai-Hyun Kim, Young-Kug Medicine (Baltimore) 7300 Radical cystectomy, which is performed to treat muscle-invasive bladder tumors, is among the most difficult urological surgical procedures and puts patients at risk of intraoperative blood loss and transfusion. Fluid management via stroke volume variation (SVV) is associated with reduced intraoperative blood loss. Therefore, we evaluated the efficacy and safety of SVV-guided fluid therapy for reducing blood loss and transfusion requirements in patients undergoing radical cystectomy. This study included 48 patients who underwent radical cystectomy, and these patients were randomly allocated to the control group and maintained at <10% SVV (n = 24) or allocated to the trial group and maintained at 10% to 20% SVV (n = 24). The primary endpoints were comparisons of the amounts of intraoperative blood loss and transfused red blood cells (RBCs) between the control and trial groups during radical cystectomy. Intraoperative blood loss was evaluated through the estimated blood loss and estimated red cell mass loss. The secondary endpoints were comparisons of the postoperative outcomes between groups. A total of 46 patients were included in the final analysis: 23 patients in the control group and 23 patients in the trial group. The SVV values in the trial group were significantly higher than in the control group. Estimated blood loss, estimated red cell mass loss, and RBC transfusion requirements in the trial group were significantly lower than in the control group (734.3 ± 321.5 mL vs 1096.5 ± 623.9 mL, P = 0.019; 274.1 ± 207.8 mL vs 553.1 ± 298.7 mL, P <0.001; 0.5 ± 0.8 units vs 1.9 ± 2.2 units, P = 0.005). There were no significant differences in postoperative outcomes between the two groups. SVV-guided fluid therapy (SVV maintained at 10%–20%) can reduce blood loss and transfusion requirements in patients undergoing radical cystectomy without resulting in adverse outcomes. These findings provide useful information for optimal fluid management during radical cystectomy. Wolters Kluwer Health 2016-05-13 /pmc/articles/PMC4902548/ /pubmed/27175706 http://dx.doi.org/10.1097/MD.0000000000003685 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 7300
Kong, Yu-Gyeong
Kim, Ji Yoon
Yu, Jihion
Lim, Jinwook
Hwang, Jai-Hyun
Kim, Young-Kug
Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial
title Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial
title_full Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial
title_fullStr Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial
title_full_unstemmed Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial
title_short Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial
title_sort efficacy and safety of stroke volume variation-guided fluid therapy for reducing blood loss and transfusion requirements during radical cystectomy: a randomized clinical trial
topic 7300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902548/
https://www.ncbi.nlm.nih.gov/pubmed/27175706
http://dx.doi.org/10.1097/MD.0000000000003685
work_keys_str_mv AT kongyugyeong efficacyandsafetyofstrokevolumevariationguidedfluidtherapyforreducingbloodlossandtransfusionrequirementsduringradicalcystectomyarandomizedclinicaltrial
AT kimjiyoon efficacyandsafetyofstrokevolumevariationguidedfluidtherapyforreducingbloodlossandtransfusionrequirementsduringradicalcystectomyarandomizedclinicaltrial
AT yujihion efficacyandsafetyofstrokevolumevariationguidedfluidtherapyforreducingbloodlossandtransfusionrequirementsduringradicalcystectomyarandomizedclinicaltrial
AT limjinwook efficacyandsafetyofstrokevolumevariationguidedfluidtherapyforreducingbloodlossandtransfusionrequirementsduringradicalcystectomyarandomizedclinicaltrial
AT hwangjaihyun efficacyandsafetyofstrokevolumevariationguidedfluidtherapyforreducingbloodlossandtransfusionrequirementsduringradicalcystectomyarandomizedclinicaltrial
AT kimyoungkug efficacyandsafetyofstrokevolumevariationguidedfluidtherapyforreducingbloodlossandtransfusionrequirementsduringradicalcystectomyarandomizedclinicaltrial